29th May 2023

Indications

Autologous stem cell transplant:

• 1st line treatment for fit patients with myeloma
• 1st line treatment for certain lymphomas
• After first relapse from high grade lymphoma
• Some solid tumours such as germ cell tumours

Allogeneic stem cell transplant:

• High risk acute leukaemia after induction chemotherapy
• Relapsed acute leukaemia
• Relapsed lymphoma
• Chronic leukaemia
• Non-haematological conditions e.g. immunodeficiency syndromes